ASH

Ashland Inc

Add to Watchlist

Advanced Chart

49.850

+0.11(0.221%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

50.265

Open

49.760

VWAP

49.91

Vol

750.51K

Mkt Cap

2.28B

Low

49.410

Amount

37.46M

EV/EBITDA(TTM)

7.43

Total Shares

50.13M

3.45B

EV/OCF(TTM)

19.82

P/S(TTM)

1.24

Ashland Inc. is a global additives and specialty ingredients company. The Company serves customers in a wide range of consumer and industrial markets, including architectural coatings, construction, energy, food and beverage, personal care and pharmaceuticals. The Company’s segments include Life Sciences, Personal Care, Specialty Additives, and Intermediates. The Life Sciences segment consists of pharmaceuticals, nutrition, agricultural chemicals, diagnostic films and fine chemicals. The Personal Care segment includes bio functionals, microbial protectants (preservatives), skin care, sun care, oral care, hair care and household solutions. The Specialty Additives segment consists of rheology and performance-enhancing additives serving the architectural coatings, construction, energy, automotive and various industrial markets. The Intermediates segment consists of the production of 1,4 butanediol (BDO) and related derivatives, including n-methyl pyrrolidone.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2026Q1

FY2026Q2

481.54M

-7.75%

1.306

+3.63%

408.77M

+0.93%

0.470

+67.91%

486.79M

+1.63%

1.279

+29.15%

Estimates Revision

The market is revising Downward the revenue expectations for Ashland Inc. (ASH) for FY2025, with the revenue forecasts being adjusted by -1.74% over the past three months. During the same period, the stock price has changed by -0.32%.

Revenue Estimates for FY2025

Revise Downward

-1.74%

In Past 3 Month

EPS Estimates for FY2025

Revise Downward

-6.55%

In Past 3 Month

Stock Price

Go Down

-0.32%

In Past 3 Month

7 Analyst Rating

Wall Street analysts forecast ASH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ASH is 63.14 USD with a low forecast of 53.00 USD and a high forecast of 77.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

3 Buy

4 Hold

0 Sell

Moderate Buy

Current: 49.850

Low

53.00

Averages

63.14

High

77.00

Current: 49.850

Low

53.00

Averages

63.14

High

77.00

Morgan Stanley

Equal Weight

initiated

$60

2025-09-08

Reason

Morgan Stanley

Price Target

$60

2025-09-08

initiated

Equal Weight

Reason

Morgan Stanley initiated coverage of Ashland with an Equal Weight rating and $60 price target. The shares are inexpensive relative to historical multiples following a prolonged turnaround, the analyst tells investors in a research note. However, the firm's enthusiasm for the shares is limited by a lack of catalysts for a positive near-term inflection. It wants to see Ashland deliver more consistent results versus consensus estimates.

BMO Capital

John McNulty

Market Perform

maintain

$60 -> $61

2025-09-02

Reason

BMO Capital

John McNulty

Price Target

$60 -> $61

2025-09-02

maintain

Market Perform

Reason

BMO Capital analyst John McNulty raised the firm's price target on Ashland to $61 from $60 and keeps a Market Perform rating on the shares after the firm's recent talks with the management team on the company's current trends, near-term growth opportunities, and thoughts on some longer-term innovation trends. Risk/reward is skewing more positively as many headwinds faced by the company over the past three years seem behind Ashland, the analyst tells investors in a research note.

Argus

Buy

downgrade

$70 -> $65

2025-08-26

Reason

Argus

Price Target

$70 -> $65

2025-08-26

downgrade

Buy

Reason

Argus lowered the firm's price target on Ashland to $65 from $70 and keeps a Buy rating on the shares. Ashland is a well-run company with a strong track record in its industry, and while its earnings have been hurt in recent quarters by reduced demand and inflationary pressures, the firm expects conditions to improve in the quarters ahead, the analyst tells investors in a research note. Ashland also has a healthy product pipeline with multiple new innovations that will allow the company to take advantage of market trends, Argus added.

UBS

Buy

maintain

$74 -> $73

2025-07-09

Reason

UBS

Price Target

$74 -> $73

2025-07-09

maintain

Buy

Reason

UBS lowered the firm's price target on Ashland to $73 from $74 and keeps a Buy rating on the shares. Better than feared tariff impacts could support downstream firms in the quarter, while commodities are likely to remain under pressure with weaker demand trends, the analyst tells investors in a research note.

JPMorgan

Overweight

maintain

$67

2025-06-27

Reason

JPMorgan

Price Target

$67

2025-06-27

maintain

Overweight

Reason

JPMorgan says June quarter business activity for many industrial and consumer companies has been trending softly, "and Ashland is most likely no different." The firm expects average prices in the company's Life Sciences segment to remain negative but continue to level out. Personal Care segment organic volumes should be modestly positive in Q3 exclusive of divestiture activity, the analyst tells investors in a research note. JPMorgan believes Ashland is a collection of "good return specialty businesses suffering from cyclical weakness." It finds the shares attractively valued at current levels and keeps an Overweight rating on the name with a $67 price target. Ashland should return to positive volume and EBITDA growth in fiscal 2026, leading to an improvement in valuation multiples, contends the firm.

Wells Fargo

Michael Sison

Buy

Maintains

$69 → $58

2025-04-09

Reason

Wells Fargo

Michael Sison

Price Target

$69 → $58

2025-04-09

Maintains

Buy

Reason

Wells Fargo lowered the firm's price target on Ashland to $58 from $69 and keeps an Overweight rating on the shares. Given increased risks in a post tariff world, the firm recommends a more defensive position within the chemicals sector into Q1 2025 results as Wells expects cautious outlook commentary.

See All Ratings

Valuation Metrics

The current forward P/E ratio for Ashland Inc (ASH.N) is 11.20, compared to its 5-year average forward P/E of 17.22. For a more detailed relative valuation and DCF analysis to assess Ashland Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Strongly Undervalued

5Y Average PE

17.22

Current PE

11.20

Overvalued PE

20.15

Undervalued PE

14.29

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Undervalued

5Y Average EV/EBITDA

10.91

Current EV/EBITDA

8.12

Overvalued EV/EBITDA

12.31

Undervalued EV/EBITDA

9.51

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Strongly Undervalued

5Y Average PS

2.07

Current PS

1.22

Overvalued PS

2.42

Undervalued PS

1.71